Santos Lucas de Azevedo, Prandi Ingrid G, Ramalho Teodorico C
Department of Chemistry, Federal University of Lavras, Lavras, Brazil.
Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czechia.
Front Chem. 2019 Dec 13;7:848. doi: 10.3389/fchem.2019.00848. eCollection 2019.
Essential to understanding life, the biomolecular phenomena have been an important subject in science, therefore a necessary path to be covered to make progress in human knowledge. To fully comprehend these processes, the non-covalent interactions are the key. In this review, we discuss how specific protein-ligand interactions can be efficiently described by low computational cost methods, such as Molecular Mechanics (MM). We have taken as example the case of the halogen bonds (XB). Albeit generally weaker than the hydrogen bonds (HB), the XBs play a key role to drug design, enhancing the affinity and selectivity toward the biological target. Along with the attraction between two electronegative atoms in XBs explained by the σ-hole model, important orbital interactions, as well as relief of Pauli repulsion take place. Nonetheless, such electronic effects can be only well-described by accurate quantum chemical methods that have strong limitations dealing with supramolecular systems due to their high computational cost. To go beyond the poor description of XBs by MM methods, reparametrizing the force-fields equations can be a way to keep the balance between accuracy and computational cost. Thus, we have shown the steps to be considered when parametrizing force-fields to achieve reliable results of complex non-covalent interactions at MM level for drug design methods.
生物分子现象对于理解生命至关重要,一直是科学中的重要课题,因此也是人类知识取得进步必须涵盖的路径。要全面理解这些过程,非共价相互作用是关键。在本综述中,我们讨论如何通过低计算成本的方法,如分子力学(MM),有效地描述特定的蛋白质 - 配体相互作用。我们以卤键(XB)为例。尽管卤键通常比氢键(HB)弱,但它们在药物设计中起着关键作用,可增强对生物靶点的亲和力和选择性。除了由σ-空穴模型解释的卤键中两个电负性原子之间的吸引力外,还会发生重要的轨道相互作用以及泡利排斥的缓解。然而,这种电子效应只能通过精确的量子化学方法很好地描述,而由于其高计算成本,这些方法在处理超分子系统时存在很大局限性。为了超越分子力学方法对卤键的粗略描述,重新参数化力场方程可能是在准确性和计算成本之间保持平衡的一种方法。因此,我们展示了在为药物设计方法在分子力学水平上实现复杂非共价相互作用的可靠结果而对力场进行参数化时应考虑的步骤。